pyridostigmine

(redirected from Mestinon SR)

pyridostigmine

 [pir″ĭ-do-stig´mēn]
an anticholinesterase; used as the bromide salt in the treatment of myasthenia gravis and as an antidote to nondepolarizing neuromuscular blocking agents such as tubocurarine.

pyridostigmine

/pyr·i·do·stig·mine/ (pir″ĭ-do-stig´mēn) a cholinesterase inhibitor, used as the bromide salt in the treatment of myasthenia gravis and as an antidote to nondepolarizing neuromuscular blocking agents.

Mestinon

An oral agent used to manage myasthenia gravis.

Adverse effects
• Muscarinic—Nausea, vomiting, diarrhoea, abdominal cramps, increased peristalsis, increased salivation, increased bronchial secretions, miosis, diaphoresis; reversed with atropine.
• Nicotinic—Muscle cramps, fasciculation and weakness.

pyridostigmine

Mestinon® Pharmacology A cholinergic used to manage Pts with myasthenia gravis, including crises Adverse effects ↑ salivation, fasciculation, abdominal cramps, diarrhea. See Reversal agent.

pyridostigmine

A CHOLINERGIC drug used in the treatment of MYASTHENIA GRAVIS. The drug is on the WHO official list. A brand name is Mestinon.

pyridostigmine

a cholinesterase inhibitor; used as the bromide in the treatment of myasthenia gravis and as an antidote to nondepolarizing muscle relaxants, e.g. tubocurarine.